ADRO

ADRO

Aduro Biotech, Inc. (Nasdaq:ADRO), a clinical-stage cancer immuno-oncology company, opened for trading on The Nasdaq Stock Market on April 15, 2015.

Format

JPEG

Source

Nasdaq, Inc.

Downloads